---
schema_version: "secwatch.filing_event.v1"
accession: "0001575872-23-000606"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2023-04-24T23:59:59+00:00"
generated_at: "2026-06-16T19:30:32.664591+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TradeUP Acquisition Corp. enters $50M common stock purchase agreement with White Lion Capital

## Summary
- Up to $50M in common stock may be sold to White Lion at 97% of VWAP post-business combination with Estrella Biopharma.
- Commitment fee of 250,000 shares of Estrella Series A Preferred Stock valued at $250,000 to be issued to White Lion.
- Investor may terminate if registration statement lapses for 45 consecutive trading days or other material breaches.
- Purchase price adjusts to 98% of VWAP after $25M of shares purchased.
- Company must register shares for resale within 30 days of business combination.

## SEC filing metadata
- accession: 0001575872-23-000606
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2023-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/0001575872-23-000606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/uptd-20220419.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001575872-23-000606
- JSON: https://secwatch.observer/filing/0001575872-23-000606.json
- Plain text: https://secwatch.observer/filing/0001575872-23-000606.txt

## Key facts
- Material Agreements
  Estrella Immunopharma, Inc. entered into Registration Rights Agreement with White Lion Capital, LLC (effective 2023-04-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: White Lion Capital, LLC
  - Effective: 2023-04-20
  source text: Concurrently with the execution of the Common Stock Purchase Agreement, the Company entered into the RRA with the White Lion in which the Company has agreed to register with the SEC the shares of Common Stock purchased by White Lion under the Common Stock Purchase Agreement and the shares of Common Stock to be issued upon the conversion of Estrella Series A Preferred Stock for resale within 30 days of the consummation of the Business Combination.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/0001575872-23-000606-index.htm
- Material Agreements
  Estrella Immunopharma, Inc. entered into Common Stock Purchase Agreement with White Lion Capital, LLC valued at up to $50,000,000 (effective 2023-04-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: White Lion Capital, LLC
  - Value: up to $50,000,000
  - Effective: 2023-04-20
  source text: On April 20, 2023, TradeUP Acquisition Corp. (the “Company”) entered into a common stock purchase agreement (the “Common Stock Purchase Agreement”) and a related registration rights agreement (the “RRA”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/0001575872-23-000606-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.